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The objective of our study was to perform phytochemical analysis and evaluate for cytotoxic activity of hydro alcoholic 
fraction (H1) of Trianthema decandra L. (Aizoaceae) against breast, liver and cervical cancers. Hydro alcoholic fraction 
was separated from methanolic extract, which was prepared by maceration method from aerial parts of T. decandra The GC-
MS analysis confirms the presence of seventeen bioactive compounds which belongs to carbohydrates, terpenoids, alkaloids, 
cardiac glycosides, fatty acids and their esters or alcohols, and their presence were supported with Fourier Transform 
Infrared Spectroscopy (FT-IR) and preliminary phytochemical analysis. Most of the compounds are biologically active and 
are known to exhibit antimicrobial and cancer preventive properties. Hydro alcoholic fraction was subjected to 
morphological evaluation and MTT cell viability assay. It has exhibited significant cytotoxic activity and their IC50 values 
were determined as 165.22 + 1.53 g/ml, 175.28 + 1.7 g/ml and 201.93 + 1.33 g/ml against MCF-7, HeLa and HepG2 
cancer cells, respectively. This bioactive fraction has exhibited cytotoxicity relatively more against breast cancer than 
cervical and liver cancers. 
Keywords: Trianthema decandra, HeLa, HepG2, MCF-7, MTT assay, GC-MS, cytotoxic. 
Introduction 
Globally, cancer is the second leading cause of 
death and is responsible for an estimated 9.6 million 
deaths in 2018. According to incidence and mortality 
of cancers, breast cancer ranks second and fifth, liver 
cancer ranks sixth & fourth, cervical cancer ranks 
eighth & eighth respectively in the world scenario. 
Where as in India, breast cancer rank first in both 
studies, cervical cancer ranks third in incidence and 
fourth in mortality1. Cervical and breast cancers are 
two major cancers among Indian women. According 
to Globocan 2018, 6.6% of death occurs due to breast 
cancer, 8.2% of death occurs due to liver cancer and 
3.2% of death occurs due to cervical cancer2. Cancer 
is uncontrolled growth of abnormal cells in the  
body. Many cancers arise from sites of infection, 
chronic irritation and inflammation. Dysregulated 
inflammation contributes too many diseases, 
including cancer3. Between 1981 and 2002, 48 out of 
65 drugs approved for cancer treatment were natural 
products, based on natural products, or mimicked 
natural products in one form or another4. The  
National Cancer Institute (NCI) has screened 
approximately 35,000 plant species for potential 
anticancer activities5. Phytochemicals exhibit their 
pharmacological activities through various mechanisms 
but may fight against disease through suppression  
of the inflammatory response. Several cytotoxic, 
chemotherapeutic, and immunomodulating agents are 
available in allopathic medicine which are of high 
cost and are associated with serious side effects and 
morbidity to treat cancer. According to World Health 
Organization (WHO) approximately 70% of deaths 
from cancer occur in low- and middle-income 
countries. Still, the search continues for an ideal 
treatment that has effectiveness, minimal side effects 
and is cost-effective which is needed for economically 
challenged patients.  
Trianthema decandra L. syn. Zaleya decandra 
(Aizoaceae) is commonly known as Gadabani (Hindi) 
and Tella galijeru6 (Telugu). It is a prostrate, diffuse 
herb, widely found both in cultivated and waste lands 
of India, some parts of Asia, Australia, Africa and 
South America, abundantly grown in rainy season. Its 
leaves are edible. Traditionally used for the treatment 
of tooth ache, wound healing, anti-diabetic, fever, 
skin diseases and various parts used to treat the  
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black quarter, bacterial infections, edema and 
rheumatitis7. Medicinal and pharmacological properties 
includes anti-inflammatory, analgesic, anti-diabetic, 
hepatoprotective, antidote to alcohol poisoning8, 
antibacterial, antifungal, aphrodisiac, adaptogenic and 
antioxidant activities9. No scientific report is available 
on anticancer properties from this species till date. 
The objective of our study was to perform 
phytochemical analysis and screen for anticancer 
activity of hydro alcoholic fraction of  
T. decandra to evaluate its cytotoxic activity against 
breast, liver and cervical cancers. 
 
Materials and Methods 
Collection and Authentication of Plant Material 
The aerial parts of T. decandra were collected in 
the monsoon season from surrounding places of 
Kakatiya University, Warangal, Telangana, India. The 
plants were authenticated by Dr. Ajmeera Raagan, 
Plants Systemic Laboratory, Department of Botany, 
Kakatiya University, Warangal, Telangana. A herbarium 
was deposited in the Department of Botany as 
Account no. KUW 1924 of Aizoaceae. The fresh 
aerial plant materials of T. decandra were carefully 
identified, collected, dried and then pulverized with 
mechanical grinder and sieved with no. 40 to  
get moderately coarse crude powder preserved in 
airtight container. 
 
Preparation of Extract and Fractions 
The crude powder (1.21 kg) was macerated with 
methanol until extraction takes place exhaustively. 
Pooled up all the filtrates after quadruple maceration and 
the obtained methanolic extract was dried using rota 
evaporator and labeled as M1. The dried M1 extract is 
dissolved in ethanol and treated with petroleum ether, 
chloroform and water by successive solvent 
fractionation method, fractions were labeled as P1 
(petroleum ether fraction), C1 (chloroform fraction) and 
H1 (Hydro alcoholic fraction). The percentage yield of 
M1, P1, C1, H1 are 5.97%, 0.68%, 1.76%, 2.68% 
respectively. The percentage yield was more with  
hydro alcoholic fraction than other fractions and 
subjected to phytochemical investigation and  
screening for anticancer properties by using in vitro 
bioassay methods. 
 
Phyto Chemical Analysis 
The qualitative chemical tests carried out for the 
identification of the different phytoconstituents 
present in the hydro alcoholic fraction H1 by using 
standard methods10-11. Fourier transform infrared 
spectroscopy (FT-IR) analysis was performed  
using Shimadzu 8400S spectrophotometer. Gas 
chromatography- mass spectrometry (GC-MS) is a 
valuable tool for reliable detection of bioactive 
constituents. This fraction was analyzed by using a 
Shimadzu GCMS-QP2010 SE equipment with GC 
parameters (DB-624, fused silica capillary column 
ZB-5 (30 mm x 0.32 mm 1D X 0.25 μm), an electron 
ionization system (70 eV), helium as carrier gas at 
constant flow rate of 1.5 ml/min and an injection 
volume of 1 μl. Injector temperature 220°C; ion-
source temperature 250°C with run time 30 min. Mass 
spectra with scan interval of 0.5 seconds and 
fragments from 350 to 650 m/z using turbo mass  
5.2 with NIST ver 2.1 MS software data library. 
 
Cell Culture 
Cell lines of HeLa, HepG2 and HEK-293 (ATCC) 
were sub-cultured in-house, in CDFD, Hyderabad. 
Cells were grown in Dulbecco’s modified Eagles medium 
(Gibco Invitrogen, Paisley, UK) supplemented with 
10% fetal bovine serum, 1% non-essential amino 
acids, 1% penicillin (1000 U/mL), 1% streptomycin 
(1000 μg/mL) and 1% amphotericin (250 U/mL) and 
incubated with 5% CO2 at 37°C. After 80% cell 
confluence, sub-cultures (conc. of 6 x 103 cell/cm2) 
were prepared with 0.25% (w/v) trypsin 0.53 mM 
EDTA solution and incubated at 37°C.  
 
Cytotoxic Activity 
H1 fraction was qualitatively screened for 
cytotoxic activity by morphological evaluation by 
treated 12 hours post-seeding with 150 g/ml and 300 
g/ml and normal HEK-293 cells with 300 g/ml 
against HeLa, HepG2 and MCF-7 cancer cell lines 
and observed cells after 24 hrs, 48 hrs and 72 hrs. 
Images were aquired by Axiovert 200M phase 
contrast microscope (10X) using Axiovision  
Rel.4.2 software. 
Quantitative estimation (IC50 values) of cytotoxic 
activity of H1 fraction was determined by MTT cell 
viability assay, which is homogeneous colorimetric 
assay, based on the conversion of a tetrazolium salt 
MTT, a pale yellow substrate, to formazan, a purple 
dye. The intensity of the product color, measured at 
550-620 nm, is directly proportional to the number of 
living cells in the culture. The cultured HeLa, MCF-7 
and HepG2 cancer cells (100 µL per well) were added 
with H1 fraction concentrations ranging from 10 to 
300 μg/ml (10, 50, 100, 150, 200, 250,  
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300 μg/ml) in triplicate after 24 hrs seeding and 
incubated for the 24 hrs, 48 hrs and 72 hrs period of 
time. To each well, 20 µL of culture medium, 15 µL 
MTT reagent per well which was made up in 
phosphate buffer saline (PBS) medium to a final 
concentration of 0.5 mg/mL. Cells were incubated for 
3 hours at 37°C until intracellular purple formazan 
crystals are visible under microscope. The MTT 
reagent was removed and 100 µL of the dimethyl 
sulfoxide (DMSO) was added to each well and mixed 
gently on an orbital shaker for one hour at room 
temperature. Absorbance at OD 570 nm was 
measured for each well on an absorbance plate reader 
(SunriseTM, TECAN). 
 
Results  
Phytochemical Analysis  
The preliminary qualitative phytochemical 
screening indicates the presence of alkaloids, 
carbohydrates, phenols or alcohols, terpenoids, 
cardiac glycosides, fatty acids, saponins, tannins and 
proteins. FT-IR spectrum was shown in Figure 1 and 
confirms the presence of phenols/alcohols, carboxylic 
acids, esters, aryl ketones, amines and amides 
functional groups which were given in Table 1.  
 
GC-MS analysis 
From GC-MS analysis, phytochemical compounds 
were identified and the retention time, peak area, and 
molecular formula and their chemical nature and 
biological properties of compounds of their 
corresponding peaks were presented in Figure 2. The 
identified chemicals corresponding to the peaks were 
determined as follows: Mome inositol (26.57%), 
methyl ester of 2-hydroxy-valeric acid (18.9%), 
hexanoic acid, 2-methyl- (7.74%), imidazole, 2-amino-5-
[(2-carboxy)vinyl]- (7.71%), decanoic acid (7.45%), 
allantoic acid (6.90%) are in major concentrations,  
dl-citrulline (3.8%), benz[e]azulene-3, 8-dione, 5-
[(acetyloxy)methyl]-3a, 4, 6a, 7, 9, 10, 10a, 10b-
octahydro-3a,10a-dihydroxy-2,10-dimethyl- (2.65%), 
octanoic acid (2.16%), 1,3-dioxolan-4-one, 5-benzyl-
2-(1,1-dimethylethyl)-5-methyl- (1.37%), strogogenin 
(1.04%), 12, 15-octadecatrienoic acid, 2-[(trimethy 
lsilyl)oxy]-1-[[(trimethylsilyl) oxy]methyl] ethyl ester, 
(Z,Z,Z) (0.99%), 9n-hexadecanoic acid (0.89%), 1H-
pyrazole, 4,5-dihydro-3-methyl- (0.66%), E-11-
tetradecenol, trimethylsilyl ether (0.59%), dasycar pidan-1-
methanol, acetate (ester) (CAS) (0.48%), malonic 
acid, bis (2-trimethylsily lethyl ester (0.41%) are in 
minimal concentrations. The biological properties 
which were mentioned in Table 2 are based on  
Dr. Duke’s phytochemical and ethno botanical databases 
from Dr. Jim Duke of the Agricultural Research 
Service/USDA. The individual chemical compound 
name, fragmentation patterns of mass spectra and 
their structures of phytoconstituents identified in  
GC-MS spectrum were illustrated in Figure 3 (a-m). 
 
 
Fig. 1 — FT-IR spectrum of hydro alcoholic fraction (H1) of Trianthema decandra. 
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Cytotoxic Activity 
From the morphology studies it is concluded that 
H1 fraction has exhibited significant cytotoxicity at 
300 g/ml against HeLa, MCF-7 and HepG2 cancer 
cell lines. The morphological changes occurred in 
cancer cells after treatment with H1 fraction were  
Table.1 — FT-IR spectroscopic profile of H1 fraction of Trianthema decandra 
Peak (Wave No. 
number cm-ˡ) 
Intensity  Type of intensity  Bond Type of vibration 
 
Functional group 
assignment 
Frequency (cm-ˡ) 
459, 547.8, 
866.07,661.61 
93.09,90.9, 
86.3,97.66 
Medium 
Weak 
N-H 
O-H 
Bending 
Bending (in plane) 
1○ amines 
Alcohols & phenols 
900-660 
770-650 
1064.7, 1097.53 87.0,82.6 Strong O-H 
CH3 
C-C-C 
C-N 
stretch Alcohols 1250-970 
 
1390.7 
1255.7 
 
79.063 
88.066 
Medium 
 
Medium 
bending (out of plane) 
stretch 
Alcohols & phenols 
Alkanes & alkenes 
Aryl ketones 
Amino 
1430-1330 
1470-1350 
1390-1370 
1450-1100 
1360-1080 
1500.67 86.46 Weak C=C Stretch Arenes 1500 
1440.87  84.978  
Strong 
 
 
C=O 
bending Ketones 1450-1400 
1658.84 73.33 Stretch Amides, carboxylic 
acids & derivatives 
1695-1630 
1724.42 
1712.85 
1757.21 
 81.32 
 80.59 
92.64 
 
Stretch 
Aldehyde/ketones 
Cyclobutanone 
1740-1720 
1720-1710 
 esters 1750-1735 
2341.6, 2359.02 59.17 Medium P-H Stretch Silane/ phosphorous  
gps/isocyanates 
2440-2280 
2615.56 91.15 Strong O-H  Stretch Carboxylic acids 3300-2500 
2928.04, 3066.9 74.73, 81.9 Strong C-H Stretch Alkanes 
Alkenes 
3000-2850 
3100-3020 
3421.8,3446.9, 
3462.3, 3481.6, 
3524.06 
63.5, 63.4, 
63.6, 63.6, 64.1 
Variant 
Weak 
N-H 
O-H (free) 
Stretch 
Stretch 
Amines 
Phenols/alcohols 
=NOH oxime 
3500-3400 
3550-3200 
3600-3500 
3873.1,  3838.4 79.4, 79.4 Strong C-H Stretch Aldehydes or ketones 2690-3840 
 
 
 
Fig. 2 — GC-MS chromatogram of hydro alcoholic fraction of Trianthema decandra. 
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Table 2 — Phytochemical compounds identified in H1 fraction by GC-MS analysis. 
S. No RT Name of the compound Mol. formula Mol.wt Peak area 
(%) 
Nature of the 
compound 
**Bio activity reported 
1 14.525 dl-citrulline C6H13N3O3 175 3.8 Non essential 
amino acid 
Stimulate the immune system 
and help detoxify ammonia 12 
2 14.833 Allantoic acid C4H8N4O4 176 6.90 Organic acid Anti-cancer 13 
3 14.833 Imidazole, 2-amino-5- 
[(2-carboxy)vinyl]- 
C6H7N3O2 153 7.71 Imidazole 
nucleus 
Antimicrobial, anti-cancer 
4 15.027 Hexanoic acid, 2-methyl- 
(CAS) 
C7 H14 O2 130 7.74 Methyl caproic 
acid 
Anti-cancer, flavour and 
fragrance agents 
5 15.175 Methyl ester of 2-hydroxy-
valeric acid 
C6 H12 O3 132 18.19 Dicarboxylic 
acid ester 
Not reported 
6 15.208 Decanoic acid C10 H20 O2 172 7.45 Capric acid Anti-cancer, anti-convulsant 
7 15.303 Mome inositol C7 H14 O6 194 26.57 Sugar alcohol Anti alopecic, anti cirrhotic, 
anti neuropathic, anti-cancer, 
cholesterolytic, lipotropic, 
Sweetener. 
8 15.517 Octanoic Acid C8H16O2 144 2.16 Caprylic acid Anti-cancer, antimicrobial, 
weight reducing agent. 
9 15.667 n-hexadecanoic acid C16H32O2 256 0.89 Fatty acid 
 
Anti-cancer, Antioxidant, 
pesticide, flavor, 5-alpha 
reductase-inhibitor, 
Antifibrinolytic, nematicide, 
antialopecic 
10 22.898 Malonic acid, bis(2-
trimethylsilylethyl ester 
C13H28O4Si2 304 0.41 Malonate 
diester 
Surgical adhesive 
11 24.35 1H-pyrazole, 4,5-dihydro-3-
methyl- 
C4H8N2 84 0.66 Methyl pyrazole Not reported 
12 25.71 9,12,15-octadecatrienoic 
acid, 2-[(trimethylsilyl)oxy]-
1- [(trimethyl silyl)oxy] methyl] 
ethyl ester, (Z,Z,Z)- 
C27H52O4Si2 496 0.99 Linolenic acid Cancer preventive, anti 
inflammatory, 
hypocholesterolemic, 
hepatoprotective, nematicide. 
13 26.44 E-11-
tetradecenol,trimethylsilyl 
ether 
C17H36OSi 284 0.59 Fatty alcoholic 
ether 
Antimicrobial activity 
14 26.998 1,3-dioxolan-4-one, 5-
benzyl-2-(1,1-dimethylethyl)-
5-methyl 
C15H20O3 248 1.37 Aromatic 
compound 
Not reported 
15 27.984 Dasycarpidan-1-methanol, 
acetate (ester) (CAS) 
C20 H26 N2 
O2 
326 0.48 New aromatic 
compound 
Not reported 
16 28.193 Benz[e]azulene-3,8-dione, 5-
[(acetyloxy)methyl]-
3a,4,6a,7,9,10,10a,10b-
octahydro-3a,10a-dihydroxy-
2,10-dimethyl- 
C19H24O6 348 2.65 New aromatic 
compound 
Not reported 
17 29.118 Strogogenin C23 H30 O8 434 1.04 Steroidal 
aglycone 
Cardenolide, cytotoxic activity13 
**Activity source: Dr. Duke's phytochemical and ethno botanical databases. 
 
compared with control and negative control which 
were illustrated in Figure 4. The elongated structured 
viable cells are morphologically turned into spherical 
shaped death cells after inhibition effect by test 
sample. In MCF-7 cells, the inhibition of activity was 
observed in wells at 150 μg/ml treatment after 72 hrs 
and death cells were present in wells at 300 μg/ml 
after 24 hrs, 48 hrs and 72 hrs. In HeLa & HepG2 
cells, morphological changes observed at 300 g/ml 
treatment after 24 hrs and death cells were present  
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Fig. 3 — (a-g) Mass chromatograms and their structures of phyto components present in hydro alcoholic fraction H1. (contd.) 
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Fig. 3 — (h-m) Mass chromatograms and their structures of phyto components present in hydro alcoholic fraction H1. 
 
after 48 and 72 hrs. There is no cytotoxic activity was 
observed after treatment of H1 at 150 g/ml against 
HeLa and HepG2 cancer cells.  
Treatment of H1 at 300 g/ml against HEK-293 
normal cells showed no significant morphological 
changes at any time point from 24 to 72 hrs when 
compared with control cells which were shown in 
Figure 5. The IC50 values of H1 fraction against three 
cell lines at different timings were compared with 
values of standard drug doxorubicin and the values 
were given in Table 3. The cytotoxic effect was 
exhibited after 24 hrs and maximum effect observed 
after 72 hrs of treatment i.e IC50 values against HeLa, 
HepG2 and MCF-7 cell lines were determined as 
175.28 + 1.7 g/ml, 201.93 + 1.33 g/ml and  
165.22 + 1.53, g/ml respectively. The percentage of 
viability cells observed at different concentrations of 
test fraction H1 against three cancer cells at 12 hrs,  
48 hrs, 72 hrs timings were graphically represented  
in Figure 6. The cytotoxic activity (IC50 values) 
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exhibited by H1 fraction compared to IC50 values of 
standard drug doxorubicin against various cancer cells 
were graphically represented in Figure 7. 
 
Discussion 
GC-MS analysis revealed that seventeen 
phytoconstituents were present, among them the 
nature of compounds are known to be carbohydrate 
(mome inositol), amino acid (dl-citrulline), fatty acids 
and their alcohols or esters or ethers (hexanoic acid, 
2-methyl-, decanoic acid, octanoic acid, n-hexadecanoic 
acid, 9, 12, 15-octadecatrienoic acid, 2-[(trimethylsilyl) 
oxy]-1-[[(trimethylsilyl) oxy]methyl] ethyl ester, (Z, Z, Z)-, 
E-11-tetradecenol, trimethyl silyl ether), steroidal 
triterpenoid (strogogenin), esters of carboxylic acids 
(methyl ester of 2-hydroxy-valeric acid, malonic acid, 
bis(2-trimethylsilylethyl ester) moieties and remaining 
nitrogenous heterocyclic compounds (dasycarpidan-1-
methanol, acetate, benz [e]azulene-3, 8-dione,  5-[(acetyloxy) 
methyl]-3a,4,6a, 7,9,10,10a,10b-octahydro-3a,10a-
dihydroxy-2,10-dim ethyl-, imidazole, 2-amino-5-[(2-
carboxy)vinyl]-, 1H-pyrazole, 4,5-dihydro-3-methyl-) 
are expected to be alkaloids. Their confirmation was 
supported by the presence of peaks represents alcoholic 
(1250-950 cm-1), carboxylic (1672.34 cm-1), esters 
(1735.9, 1784.2 cm-1), 10, 20, 30 amines (1360-1080 cm-1, 
3500-3300 cm-1 of C-N and N-H) as main functional 
groups from IR analysis and has shown positive 
results with corresponding chemical tests. From 
spectral analysis (FT-IR and GC-MS) it is clear that 
maximum concentration of alcoholic compounds and 
medium and long chain fatty acids are present in H1 
fraction which is supported with information that, 
49.365% of area is noted for the peak 3421.83 cm-1 
(O-H groups) and 29.767% of area is noted for the 
peak 2928.04 cm-1 (alkanes/alkenes) in FT-IR 
spectrum which might be mome inositol  
(major compound) and fatty acids, remaining organic 
compounds. 
Most of the identified compounds have been 
reported to possess interesting biological activities 
which were mentioned in Table 2. Mome inositol is 
carbocyclic sugar, the major component which is the 
precursor molecule of inositol hexaphosphate IP(6), 
appears to enhance the anticancer effect against breast 
metastases, and improve quality of life through  
 
 
 
Fig. 5 — Morphological evaluation of hydroalcoholic fraction 
(H1) against HEK-293 normal cell lines. 
 
Fig. 4 — Morphological evaluation of H1 fraction against HeLa, HepG2 and MCF-7 cancer cell lines. 
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Table 3 — Cytotoxicity of H1 fraction against various cancers by MTT assay 
S.No Type of cancer cell lines Test sample IC50 values (μg/ml) 
24 hrs 48 hrs 72 hrs 
1 He La H1 199.01 + 1.27 186.13 + 1.21 175.28 + 1.7 
2 MCF-7 H1 190.80 + 0.85 175.54 + 1.75 165.22 + 1.53 
3 HeLa & MCF-7 Doxorubicin 52.37 + 0.7 μM 49.13 + 0.5 μM 48.62 + 0.4 μM 
4 HepG2 H1 230.29 + 1.31 210.71+ 1.34 201.93 + 1.33 
5 HepG2 Doxorubicin 65.57 + 0.5μM 61.37 + 0.6 μM 58.69 + 0.9 μM 
 
 
 
Fig. 6 — i), ii), iii) represents of MTT assay of H1 fraction of Trianthema decandra (T.D) after 24, 48 and 72 hrs treatment  against 
HeLa, MCF-7 and HepG2 cancer cell lines and iv) Represents comparison of cytotoxic activity of H1 fraction against three cell lines 
along with standard drug doxorubicin at different timings.  
 
blocking progression along the cell cycle by 
counteracting the activation of the ERK pathway14-16. 
Alkaloids are natural compounds mostly contains 
basic nitrogen atoms and are produced by plants. 
Some alkaloids exhibits antitumor properties by 
regulates p21WAF1/CIP1 and induces apoptosis in 
p53-dependent (MCF-7) breast cancer cell line17. 
Dasycarpidan-1-methanol, acetate (ester) (CAS) is an 
ester of monoterpenoid indole alkaloid might be 
exhibited cytotoxic properties. Imidazole, 2-amino-5-
[(2-carboxy) vinyl]- compound might have anticancer 
property against breast cancer because imidazole 
conjugates possess good PI3K inhibitory activity via 
PI3K/Akt/mTOR signaling pathway in breast cancer 
cell lines18. Many investigations demonstrated19-20 that 
capric, caprylic and caproic acids are medium chain 
fatty acids exerted significant anticancer activity 
against breast and other cancer cells preferentially kill 
tumour cells without causing adverse effects on 
normal cells. Methyl hexanoic acid, decanoic acid, 
 
Fig. 7 — Graphical representation of cytotoxic activity of 
H1 against various cancer cell lines. 
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octanoic acid are medium chain fatty acids, n-
hexadecanoic acid is a long chain fatty acid and 
9,12,15-octadecatrienoic acid, 2-[(trimethyl silyl) 
oxy]-1-[[(trimethylsilyl)oxy]methyl]ethyl ester, (Z,Z,Z)- 
is an ester of poly unsaturated linolenic acid which are 
known to be anticancer compounds. α-linolenic acid 
and its metabolite docosahexaenoic acid (DHA) 
exhibits anticancer activity against breast cancer by 
which they could shift the pro-survival estrogen signal 
to a pro-apoptotic effect via GPER1-cAMP-PKA 
signaling response, blunting EGFR, Erk 1/2 and AKT 
activity in MCF-7 cells21. Most of the cardiac 
glycosides (CGs) are potential anticancer agents as 
they impart their antiproliferative effect by targeting 
multiple pathways. They exhibits cytotoxic activities 
against breast cancer via p-Akt signaling pathway 
was down regulated and p-ERK signaling pathway 
being activated in MCF-7 cells and have emerged22. 
Strogogenin is a cardenolide which is an aglycone, 
might be formed by lysis of glycosidic linkage of 
glycosides present in H1 fraction and might exhibits 
cytotoxic properties. The biological properties of  
the complex organic compounds (14th, 15th, 16th 
compounds mentioned in Table 2) are not reported 
but they might be possess cytotoxic properties or 
have exerted synergistic effect along with other 
compounds present in H1 fraction to exhibit 
significant cytotoxic activity. 
From the results, H1 fraction has showed the 
significant cytotoxicity against breast, liver and 
cervical cancers which might be due to either 
synergistic effect of all the chemical components or a 
target specific molecular constituents by inhibiting the 
activation of receptor tyrosine kinases (RTKs) which 
influence ERK or other downstream signaling 
pathways, there by inhibition of cell growth, 
differentiation was observed. The higher cytotoxic 
effect is against breast cancer cells due to the presence 
of components which might be more likely to bind 
with cell specific functional proteins present in 
mitochondria of breast cancer cells than the cell 
specific biomolecules present in liver and cervical 
cancer cells and exerted maximum inhibition activity 
on breast cancer cells might be through lowering the 
over expression levels of the HER2 protein, either 
through gene amplification or through transcriptional 
deregulation via the PI3K/AKT/β-catenin downstream 
signaling pathway. Negative control results indicated 
that the solvent does not shown any effect against 
cancer cells and it also has shown non toxic activity 
on HEK-293 normal cell lines i.e the hydro alcoholic 
fraction of T. decandra has been proved to be safer 
for normal cell lines and effective in killing breast 
cancer cells. 
From the above study it is concluded that, 
screening for anticancer properties of hydro alcoholic 
fraction H1 of T. decandra exhibited significant 
cytotoxic activity against breast cancer. The 
phytochemical investigation showed the existence of 
various compounds with different chemical structures. 
Further researches are needed for identification of 
bioactive compounds using various strategies to 
separate bioactive fractions or isolation and 
purification of individual constituents such as 
complex organic compounds and evaluate their 
cytotoxicity for both reported and non reported 
molecules and also elucidate the mechanism via 
cellular pathways of cytotoxic activities which may be 
used as templates for anticancer drug molecules.  
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